These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
513 related items for PubMed ID: 18091526
21. Sirolimus and everolimus induced pneumonitis in adult renal allograft recipients: experience in a center. Rodríguez-Moreno A, Ridao N, García-Ledesma P, Calvo N, Pérez-Flores I, Marques M, Barrientos A, Sánchez-Fructuoso AI. Transplant Proc; 2009; 41(6):2163-5. PubMed ID: 19715862 [Abstract] [Full Text] [Related]
22. Intrarenal injection of bone marrow-derived angiogenic cells reduces endothelial injury and mesangial cell activation in experimental glomerulonephritis. Uchimura H, Marumo T, Takase O, Kawachi H, Shimizu F, Hayashi M, Saruta T, Hishikawa K, Fujita T. J Am Soc Nephrol; 2005 Apr; 16(4):997-1004. PubMed ID: 15744001 [Abstract] [Full Text] [Related]
23. Glomerular macrophage modulation affects mesangial expansion in the rat after renal ablation. van Goor H, van der Horst ML, Fidler V, Grond J. Lab Invest; 1992 May; 66(5):564-71. PubMed ID: 1573851 [Abstract] [Full Text] [Related]
25. A murine model of site-specific renal microvascular endothelial injury and thrombotic microangiopathy. Hohenstein B, Braun A, Amann KU, Johnson RJ, Hugo CP. Nephrol Dial Transplant; 2008 Apr; 23(4):1144-56. PubMed ID: 18045820 [Abstract] [Full Text] [Related]
26. Apoptosis and treatment of chronic allograft nephropathy with everolimus. Lutz J, Zou H, Liu S, Antus B, Heemann U. Transplantation; 2003 Aug 15; 76(3):508-15. PubMed ID: 12923436 [Abstract] [Full Text] [Related]
27. Delayed mTOR inhibition with low dose of everolimus reduces TGFβ expression, attenuates proteinuria and renal damage in the renal mass reduction model. Kurdián M, Herrero-Fresneda I, Lloberas N, Gimenez-Bonafe P, Coria V, Grande MT, Boggia J, Malacrida L, Torras J, Arévalo MA, González-Martínez F, López-Novoa JM, Grinyó J, Noboa O. PLoS One; 2012 Aug 15; 7(3):e32516. PubMed ID: 22427849 [Abstract] [Full Text] [Related]
28. Rapamycin prevents early steps of the development of diabetic nephropathy in rats. Yang Y, Wang J, Qin L, Shou Z, Zhao J, Wang H, Chen Y, Chen J. Am J Nephrol; 2007 Aug 15; 27(5):495-502. PubMed ID: 17671379 [Abstract] [Full Text] [Related]
29. Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside. Hoyer JR, Mauer SM, Michael AF. J Lab Clin Med; 1975 May 15; 85(5):756-68. PubMed ID: 1091713 [Abstract] [Full Text] [Related]
30. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats. Song J, Meng L, Li S, Qu L, Li X. Vascul Pharmacol; 2009 May 15; 50(5-6):185-93. PubMed ID: 19563735 [Abstract] [Full Text] [Related]
31. Renoprotective effects of sirolimus in non-immune initiated focal segmental glomerulosclerosis. Rangan GK, Coombes JD. Nephrol Dial Transplant; 2007 Aug 15; 22(8):2175-82. PubMed ID: 17550925 [Abstract] [Full Text] [Related]
32. Long-term treatment of sirolimus but not cyclosporine ameliorates diabetic nephropathy in the rat. Wittmann S, Daniel C, Stief A, Vogelbacher R, Amann K, Hugo C. Transplantation; 2009 May 15; 87(9):1290-9. PubMed ID: 19424027 [Abstract] [Full Text] [Related]
33. Transplanted mesenchymal stem cells accelerate glomerular healing in experimental glomerulonephritis. Kunter U, Rong S, Djuric Z, Boor P, Müller-Newen G, Yu D, Floege J. J Am Soc Nephrol; 2006 Aug 15; 17(8):2202-12. PubMed ID: 16790513 [Abstract] [Full Text] [Related]
34. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. Mu W, Ouyang X, Agarwal A, Zhang L, Long DA, Cruz PE, Roncal CA, Glushakova OY, Chiodo VA, Atkinson MA, Hauswirth WW, Flotte TR, Rodriguez-Iturbe B, Johnson RJ. J Am Soc Nephrol; 2005 Dec 15; 16(12):3651-60. PubMed ID: 16251240 [Abstract] [Full Text] [Related]
35. Melatonin ameliorates oxidative stress, inflammation, proteinuria, and progression of renal damage in rats with renal mass reduction. Quiroz Y, Ferrebuz A, Romero F, Vaziri ND, Rodriguez-Iturbe B. Am J Physiol Renal Physiol; 2008 Feb 15; 294(2):F336-44. PubMed ID: 18077597 [Abstract] [Full Text] [Related]
36. Rapamycin has dual opposing effects on proteinuric experimental nephropathies: is it a matter of podocyte damage? Torras J, Herrero-Fresneda I, Gulias O, Flaquer M, Vidal A, Cruzado JM, Lloberas N, Franquesa Ml, Grinyó JM. Nephrol Dial Transplant; 2009 Dec 15; 24(12):3632-40. PubMed ID: 19671594 [Abstract] [Full Text] [Related]
37. Protein kinase C-beta inhibition attenuates the progression of nephropathy in non-diabetic kidney disease. Kelly DJ, Edgley AJ, Zhang Y, Thai K, Tan SM, Cox AJ, Advani A, Connelly KA, Whiteside CI, Gilbert RE. Nephrol Dial Transplant; 2009 Jun 15; 24(6):1782-90. PubMed ID: 19155535 [Abstract] [Full Text] [Related]
38. Potential role of proliferation signal inhibitors on atherosclerosis in renal transplant patients. Andrés V, Castro C, Campistol JM. Nephrol Dial Transplant; 2006 Jul 15; 21 Suppl 3():iii14-7. PubMed ID: 16815851 [Abstract] [Full Text] [Related]
39. Monoclonal antibody 1-22-3-induced glomerulonephritis in uninephrectomized rats as a model of progressive renal failure. Tomita M, Sogabe H, Nakazato S, Nakatsuji S, Noto T, Hamada K, Kawachi H, Shimizu F, Matsuo M, Mutoh S. Nephrol Dial Transplant; 2005 Nov 15; 20(11):2358-67. PubMed ID: 16091375 [Abstract] [Full Text] [Related]
40. Advanced oxidation protein products accelerate renal fibrosis in a remnant kidney model. Li HY, Hou FF, Zhang X, Chen PY, Liu SX, Feng JX, Liu ZQ, Shan YX, Wang GB, Zhou ZM, Tian JW, Xie D. J Am Soc Nephrol; 2007 Feb 15; 18(2):528-38. PubMed ID: 17202414 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]